Soderholm
Andreas Soderholm, Alingsas SE
Patent application number | Description | Published |
---|---|---|
20130031885 | POCKET FILTER ASSEMBLY - The present invention relates to a gas filter assembly ( | 02-07-2013 |
Brian Soderholm, Snellville, GA US
Patent application number | Description | Published |
---|---|---|
20140240966 | SUPPLEMENTAL, BACKUP OR EMERGENCY LIGHTING SYSTEMS AND METHODS - A supplemental lighting system includes a charging circuit having a reference voltage for the charging circuit set through changes to reference resistances, and/or having an output voltage, current or power set through a connector configuration. In one example, a battery storage connector can be used to select a particular resistance for setting the reference voltage. Additionally, a supplemental lighting system may have a rechargeable battery coupled to a low-voltage part of the circuit, for example protected by an isolation circuit. Furthermore, a lithium ion or similar rechargeable battery supply can include a circuit for allowing it to be used with a circuit designed for a NiCad powered system or with a circuit designed for a lithium ion powered system. | 08-28-2014 |
Chad Soderholm, Willowbrook, IL US
Patent application number | Description | Published |
---|---|---|
20160091185 | METHODS AND APPARATUS FOR LIGHTING AN AREA - An example light-weight, portable, and flexible light bank is disclosed. The example apparatus includes an array of flexible LED (light emitting diodes) strips affixed to a cloth, fabric or rag-like material of a various sizes and shapes with a hook and loop mounting system to attach to various suitable mounting accessories. The apparatus can be easily rolled up or folded like a rag for storage or transport. The lights feature waterproof and non-waterproof versions of various color temperatures, functions and brightness. The lights can be daisy-chained (linked) together to create a larger light source. The light system can be held, hung, and/or mounted to objects. Battery packs and solar panel battery charger can be stacked and mounted behind the light bank. | 03-31-2016 |
Charles Gordon Soderholm, Mankato, MN US
Patent application number | Description | Published |
---|---|---|
20150017311 | PARTIAL NEUTRALIZATION OF FREE FATTY ACID MIXTURES WITH POTASSIUM, LIVESTOCK FEED COMPOSITIONS INCLUDING THEM, AND METHODS OF MAKING SAME - This disclosure describes compositions that include a partially neutralized mixture of free fatty acid and a potassium salt of a fatty acid in which the potassium salt of the fatty acid is present in a molar ratio amount in the range of from about 10% to about 40% of the amount of the free fatty acid based upon the theoretical requirement to accomplish total neutralization of all fatty acid in the composition, animal feed compositions that include such compositions, and methods of preparing such compositions. | 01-15-2015 |
Jan Soderholm, Borga FI
Patent application number | Description | Published |
---|---|---|
20100170655 | Air Supply Unit - The object of the invention is an air supply unit ( | 07-08-2010 |
Jonas Soderholm, Linghem SE
Patent application number | Description | Published |
---|---|---|
20090074803 | IMMUNOGEN PLATFORM - Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines. | 03-19-2009 |
20090214593 | IMMUNOGEN PLATFORM - Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines. | 08-27-2009 |
20110150922 | IMMUNOGEN PLATFORM - Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines. | 06-23-2011 |
20120010394 | IMMUNOGEN PLATFORM - Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines. | 01-12-2012 |
20150051388 | IMMUNOGEN PLATFORM - Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines. | 02-19-2015 |
Jonathan F. Soderholm, Richmond, CA US
Patent application number | Description | Published |
---|---|---|
20130225611 | Compositions and Methods for Reducing Cancer Cell Proliferation and Modulating Importin-Beta Function - The present disclosure provides methods of reducing proliferation of cancer cells. The methods include contacting the cancer cells with a 2,4-diaminoquinazoline compound. Also provided are methods of modulating importin-beta function (e.g., importin-beta-mediated nuclear import) in eukaryotic cells. The methods include contacting the eukaryotic cells with a 2,4-diaminoquinazoline compound. Pharmaceutical formulations that include a 2,4-diaminoquinazoline compound are also provided. | 08-29-2013 |
Karl Johan Marten Soderholm, Helsingborg SE
Patent application number | Description | Published |
---|---|---|
20080243086 | BLOOD EXPOSURE PREVENTION IN VASCULAR ACCESS DEVICES - An apparatus for preventing blood exposure or contamination upon withdrawal of a hypodermic needle is provided. The apparatus may include a needle having a tip and a shield configured to at least partially entrap the needle tip upon withdrawal of the needle. The apparatus may further include a blood stabilizing material disposed such that upon withdrawal of the needle the blood stabilizing material is disposed in operative association with the needle tip such that blood carried by the needle is prevented from escaping the apparatus. In some exemplary implementations, the blood stabilizing material may be disposed on one or more surfaces of the shield. The shield of the hypodermic needle may include protective device and/or a housing for shielding the needle tip upon withdrawal. The housing may be adapted to at least partially cover the needle tip upon withdrawal of the needle. In some implementations, the housing may be adapted to allow the protective device to shield the needle before the needle is completely withdrawn. | 10-02-2008 |
20080243092 | BLOOD EXPOSURE PREVENTION IN VASCULAR ACCESS DEVICES - An extravascular system includes a catheter assembly, a needle assembly, and a hemostatic adapter. The catheter assembly defines a lumen extending from an opening at a distal end thereof to a catheter hub at a proximal end thereof. The needle assembly includes a needle hub disposed at a proximal end of a needle disposed within the lumen defined by the catheter assembly. The needle has a needle tip extending from the opening of the catheter assembly. The hemostatic adapter defines a passage and is adapted to be operatively associated with the needle assembly and the catheter assembly. The hemostatic adapter further includes at least one liquid-reactive material adapted to at least substantially seal the passage upon contact with one or more liquids. The liquid-reactive material is selected and configured to morph upon contact with liquids to provide a mechanical barrier to prevent blood flow. A fluid may be injected into the lumen and/or passage by way of an optional port to provide a fluidic barrier in addition to the mechanical barrier. | 10-02-2008 |
Peter Soderholm, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20130261375 | Modular Implantable Medical Pump - An implantable medical pump system can include a blood pump comprising a pump housing defining a passage therethrough and a rotor within the passage. The blood pump further includes one or more elements at least partially contained within the housing adapted to actuate the rotor to drive fluid though the passage. The pump housing includes at least one coupling feature. The system further includes an inflow cannula defining a lumen therethrough. The inflow cannula is adapted to be mechanically coupled to the at least one coupling feature. | 10-03-2013 |
20150133719 | MODULAR IMPLANTABLE MEDICAL PUMP - An implantable medical pump system can include a blood pump comprising a pump housing defining a passage therethrough and a rotor within the passage. The blood pump further includes one or more elements at least partially contained within the housing adapted to actuate the rotor to drive fluid though the passage. The pump housing includes at least one coupling feature. The system further includes an inflow cannula defining a lumen therethrough. The inflow cannula is adapted to be mechanically coupled to the at least one coupling feature. | 05-14-2015 |
20160038664 | MODULAR IMPLANTABLE MEDICAL PUMP - An implantable medical pump system can include a blood pump comprising a pump housing defining a passage therethrough and a rotor within the passage. The blood pump further includes one or more elements at least partially contained within the housing adapted to actuate the rotor to drive fluid though the passage. The pump housing includes at least one coupling feature. The system further includes an inflow cannula defining a lumen therethrough. The inflow cannula is adapted to be mechanically coupled to the at least one coupling feature. | 02-11-2016 |